Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.

Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD, Arnett FC, Targoff IN, Genth E, Love LA, Miller FW.

Arthritis Rheum. 2005 Aug;52(8):2433-8.

2.

Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.

Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV.

Arthritis Rheum. 2004 Jan;50(1):209-15.

3.

Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis.

Satoh T, Okano T, Matsui T, Watabe H, Ogasawara T, Kubo K, Kuwana M, Fertig N, Oddis CV, Kondo H, Akahoshi T.

J Rheumatol. 2005 Sep;32(9):1727-33.

PMID:
16142868
4.

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies.

Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC, Joffe MM, Plotz PH.

Arthritis Rheum. 1991 Nov;34(11):1391-6.

PMID:
1953817
5.

Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.

Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL.

Medicine (Baltimore). 2005 Jul;84(4):231-49.

6.

Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.

Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M.

Arthritis Rheum. 2006 Jun;54(6):2004-9.

7.

[Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].

Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2006 Apr;29(2):85-93. Review. Japanese.

8.

Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.

Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.

J Neurol. 2002 Jan;249(1):69-75.

PMID:
11954871
9.

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW.

Medicine (Baltimore). 1991 Nov;70(6):360-74.

PMID:
1659647
10.

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.

Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG.

Ann Rheum Dis. 2006 Dec;65(12):1635-8. Epub 2006 May 5.

11.

A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD.

J Am Acad Dermatol. 2006 Apr;54(4):597-613. Epub 2006 Jan 23. Review.

PMID:
16546580
12.

Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Chen YJ, Wu CY, Shen JL.

Br J Dermatol. 2001 Apr;144(4):825-31.

PMID:
11298544
13.

[Myositis-specific autoantibodies and their clinical significance].

Suzuki S.

Brain Nerve. 2011 Nov;63(11):1197-203. Review. Japanese.

PMID:
22068472
14.

Clinical implications of autoantibody screening in patients with autoimmune myositis.

Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.

Autoimmunity. 2006 May;39(3):217-21.

PMID:
16769655
15.

Immunoserological aspects of idiopathic inflammatory muscle disease.

Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T.

Wien Klin Wochenschr. 2000 Aug 25;112(15-16):722-7.

PMID:
11020964
16.

Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.

Váncsa A, Gergely L, Ponyi A, Lakos G, Németh J, Szodoray P, Dankó K.

Joint Bone Spine. 2010 Mar;77(2):125-30. doi: 10.1016/j.jbspin.2009.08.008. Epub 2010 Feb 25.

PMID:
20188618
17.

Immune manifestations of inflammatory muscle disease.

Targoff IN.

Rheum Dis Clin North Am. 1994 Nov;20(4):857-80. Review.

PMID:
7855326
18.

Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria.

Mastaglia FL, Phillips BA.

Rheum Dis Clin North Am. 2002 Nov;28(4):723-41. Review.

PMID:
12510664
19.

Clinical significance of specific autoantibodies in juvenile dermatomyositis.

Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED.

J Rheumatol. 1996 Oct;23(10):1794-7.

PMID:
8895161
20.

Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.

Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M.

Arthritis Rheum. 2006 Oct 15;55(5):791-8.

Supplemental Content

Support Center